SecBot SecBot
SECBOTREPLAY Home › Report › LMAT

LMAT · LeMaitre Vascular filed a definitive proxy statement for its 2026…

LEMAITRE VASCULAR INC · DEFA14A filed Apr 14, 2026 at 07:36 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 14, 2026 at 07:36 ET

LeMaitre Vascular filed a definitive proxy statement for its 2026 Annual Meeting, where shareholders will vote on the election of two directors, approval of executive compensation, and ratification of the independent auditor. This follows a recent board change where a director stepped down and was replaced, indicating a board reshuffling.

  • 2026 Annual Meeting will be held on June 2, 2026
  • Proposals include election of two directors, approval of executive compensation, and ratification of the auditor
  • Board size reduced from eight to seven members
  • Director Bridget Ross will not stand for re-election

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access